Globalpharma to source new technologies from European pharmaceutical market

This agreement allows The Mackenzie & Stuart Group to act on behalf of Globalpharma for the outsourcing of ownership rights (product licenses) to help develop Globalpharma's brands. The acquisition of product licenses will allow Globalpharma to manufacture and market specific products in the Middle East and GCC countries.

Mackenzie & Stuart Group, a European based consulting group, was established to facilitate trade between the Middle East and international groups. Mackenzie & Stuart's activities focus on brands in various sectors including the pharmaceutical industry, the food and beverage market, boating and machinery.

Mr. Paolo Cappellini, Chief Executive officer, says, "The Mackenzie & Stuart Group has recently increased its focus on the branded pharmaceutical market to support the activities of Globalpharma LLC. The relationship between Mackenzie & Stuart Group and Globalpharma, demonstrated its first success with Globalpharma recently signing an agreement with Tiverton Laboratories, a member of the Alinter group, to manufacture and market Tiverton pharmaceuticals."

Mr Khalid Bin Kalban, Managing Director and Chief Executive Officer of Dubai Investments PJSC and Chairman of Globalpharma says, "Globalpharma is delighted to have signed this agreement with The Mackenzie & Stuart Group. We hope that this will further consolidate our position as a leading pharmaceutical manufacturer."

Dr Maged Amer, Acting General Manager, Globalpharma, adds, "This agreement will facilitate the sourcing of important new products to further increase our portfolio of pharmaceutical products in the Middle East and GCC countries. We will work with The Mackenzie & Stuart Group to strengthen our position in the market and in preparation for entering the European pharmaceutical market."